Home » Topics » Regulatory

Regulatory
RSS

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

No Comments

Shire seeks approval of Adderall XR in adults

Dec. 23, 2002

No Comments

Kytril available in oral solution for CINV and RINV

Dec. 23, 2002

No Comments

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

Dec. 20, 2002

No Comments

E.U. approval obtained for use of Enbrel in psoriatic arthritis

Dec. 20, 2002

No Comments

Lantus: E.U. approval for flexible use, positive opinion for pediatric use

Dec. 19, 2002

No Comments

Approvable letter for Advair Diskus

Dec. 19, 2002

No Comments

Extended-release Cipro cleared for uncomplicated urinary tract infections

Dec. 18, 2002

No Comments

Data supporting use of Risperdal for bipolar disorder submitted to FDA

Dec. 17, 2002

No Comments

Lilly seeks expanded indication for Gemzar in Europe

Dec. 17, 2002

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approval for Xalatan as first-line therapy for elevated IOP

Shire seeks approval of Adderall XR in adults

Kytril available in oral solution for CINV and RINV

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

E.U. approval obtained for use of Enbrel in psoriatic arthritis

Lantus: E.U. approval for flexible use, positive opinion for pediatric use

Approvable letter for Advair Diskus

Extended-release Cipro cleared for uncomplicated urinary tract infections

Data supporting use of Risperdal for bipolar disorder submitted to FDA

Lilly seeks expanded indication for Gemzar in Europe

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Regulatory RSS

Regulatory
RSS